Skip to main content

stock

PGEN · PRECIGEN, INC.

What PRECIGEN, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live PGEN price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PGEN.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
358,035,247 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-361.8%
ROA
-92.6%

Health

Current ratio
4.6x
Debt/equity
2.2x

Deep value

NCAV
$7.66M
NCAV per share
$0.02
Price/NCAV
Locked
NNWC
-$56.49M
NNWC per share
-$0.16
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$54.98M—Gross profit: unreported by this company.$22.64M$20.07M
10-Q filed 2026-08-04
2026-03-31$23.25M—Gross profit: unreported by this company.-$5.99M-$7.93M
10-Q filed 2026-05-13
2025-12-31——Gross profit: unreported by this company.—-$23.46M
DEF 14A filed 2026-04-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——Gross profit: unreported by this company.—-$146.34M
10-Q filed 2025-11-13
2025-06-30$856,000—Gross profit: unreported by this company.-$31.76M-$26.64M
10-Q filed 2026-08-04
2025-03-31$1.34M—Gross profit: unreported by this company.-$22.60M-$54.15M
10-Q filed 2026-05-13
2024-12-31——Gross profit: unreported by this company.—-$19.69M
DEF 14A filed 2026-04-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——Gross profit: unreported by this company.—-$23.98M
10-Q filed 2025-11-13
Assets
$170.30M
Equity
$43.58M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$9.68M-$110.51M-$250.60M-$89.83M
2024-12-31$3.92M-$135.03M-$126.20M-$76.76M
2023-12-31$6.22M-$99.76M-$95.90M-$68.47M
2022-12-31$26.91M—$28.30M-$69.97M
2021-12-31$14.27M—-$92.20M-$63.02M
2020-12-31$31.99M—-$170.52M-$84.55M
2019-12-31$90.72M—-$322.32M-$173.81M
2018-12-31$151.18M-$505.61M-$509.34M-$165.83M
2017-12-31$219.46M-$137.89M-$117.02M-$150.39M
2016-12-31$190.93M-$125.17M-$186.61M-$80.62M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

  • Point72

    Period Tue 30 Jun 2026

    0.0%Trimmed

All funds

News

Stories that named PGEN, and the market events around them.

Sign in to see this

Board

The PGEN board could not be loaded.

Retry the PGEN board

nakagai

Signals on PGEN come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PGEN board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.